Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Anterior Iliac Crest Bone Graft (AICBG)
Document related concepts
no text concepts found
Transcript
C a th e t e r P l a c e m e n t Anterior Iliac Crest Bone Graft (AICBG) T e ch n i q u e Daniel Taub, MD, DDS - Robert Diecidue, MD, DMD, MSPH Oral and Maxillofacial Surgery Thomas Jefferson University Hospital Philadelphia, PA This material is provided for educational purposes and represents the technique used by the above surgeon. Catheter placement is provided for guidance only and is subject to the individual expertise, experience and school-of-thought of the surgeon placing the catheter. This protocol is not to be construed as I-Flow’s specific recommendation. Sample Protocol Drug Manufacturers’ Recommended Dose Drug Pump Used: PM022: 100 ml x 2 ml/hr (1) 5” ON-Q Soaker® Catheter Maximum Maximum 24 Hour Dose Drugs in Pump: 100 ml of 0.5% bupivacaine Catheter Placement: 3 inches superior and lateral to incision tunnel the catheter through the skin, subcutaneous fat and the fascia. The ON-Q Soaker Catheter is placed along the bone harvest site. The periosteum is reapproximated and the wound is closed in layers. Catheter Securement Technique: Catheter is secured with Steri-Strips™. The flow restrictor is placed on the skin and secured with a clear occlusive dressing. Results with ON-Q: Percocet® or the physician’s pain medication of choice should be available for breakthrough post operative pain. Before ON-Q After ON-Q Pain Management Method: NSAIDs/narcotics opioids for breakthrough pain only Average Narcotic Usage: one week 3 days Average Length of Stay: 3-4 days 2 days Bupivacaine (Marcaine®, Sensorcaine®) 400 mg Levobupivacaine (Chirocaine®) 695 mg Ropivacaine (Naropin®) 770 mg Maximum Total Dose (24 hour dose not specified) Lidocaine (Xylocaine) 300 mg All local anesthetics are without epinephrine and manufacturer recommendations should be regarded as guidelines for use in adults. Other Notes: Subjective data per patient report: within 24 hours after AICBG pain score is 0/10. 24 hours after removal of catheter pain levels have increased to 4-5/10 with overall opioid requirement decreased. CAUTIONS • Medications used with this system should be administered in accordance with instructions provided by the drug manufacturer (see guidelines above). Surgeon is responsible for prescribing drug based on each patient’s clinical status (e.g., age, body weight, disease state of patient). • Vascoconstrictors such as Epinephrine or Adrenaline are not necessary and may not be recommended for continuous infusions. • Refer to ON-Q PainBuster Directions for Use for full instructions on using the ON-Q PainBuster System. 1305180A Page 1 of 2 AICBG These illustrations are for general guidance only and not intended to be interpreted as precise anatomical illustrations. iNTRAORAL DEFECT BONE HARVESTED WITH CATHETER PLACEMENT CATHETER PLACEMENT SECUREMENT 20202 Windrow Drive Lake Forest, CA 92630 Phone: 800-448-3569/949-206-2700 www.iflo.com " +Ê-Ê /Ê",\ UÊÊ-}vV>ÌÞÊLiÌÌiÀÊ ÊÊ «>ÊÀiivÊÌ >Ê>ÀVÌVÃ UÊÊ-}vV>ÌÞÊiÃÃÊii`Ê Ê ÊvÀÊ>ÀVÌVÃ Rx only I-Flow, ON-Q, PainBuster and Soaker are registered trademarks of I-Flow Corporation. Redefining Recovery is a trademark of I-Flow Corporation. © 2007 I-Flow Corporation. All rights reserved. 1305180A Page 2 of 2
